Oncopeptides News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oncopeptides. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oncopeptides Today - Breaking & Trending Today

FDA Officially Withdraws Approval of Oncopeptides Pepaxto

By Colin Kellaher The Food and Drug Administration has officially pulled its authorization of the anticancer drug Pepaxto from Swedish biotech Oncopeptides.. ....

Colin Kellaher , Drug Administration , Article Normal , Cancer Drugs , Scientific Research Services , Healthcare Life Sciences , Business Consumer Services , Specialized Drugs Medications , Medical Research Services , Drug Discovery Development , Healthcare Support Services , Diagnostic Medical Research Services , Regulation Government Policy , New Products Services , Product Service Approvals , Corporate Industrial News , Products Services , Political General News , Medical Conditions , Content Types , Factiva Filters , C Amp Ampe Industry News Filter , Onco Sk , Se Onco , Government Policy , New Products ,

Oncopeptides : complete first sales of Pepaxti in Greece

June 19, 2023

Oncopeptides today announced its first named patient sales of its flagship drug Pepaxti in Greece. The sales were made possible through. | June 19, 2023 ....

Monica Shaw , David Augustsson , European Union , Corporate Affairs , European Economic Area , Annual General Meeting , Nasdaq Stockholm , Oncopeptides Ab Publ Stock Exchange , Press Release , Ossible Onco Se0009414576 ,

Oncopeptides AB - Holger Lembrer will leave his role as Chief Financial Officer at Oncopeptides

Oncopeptides AB , a biotech company focused on difficult-to-treat cancers, today announced that Holger Lembrer, Chief Financial Officer has decided to leave Oncopeptides to pursue a new role in. | June 15, 2023 ....

United Kingdom , Holger Lembrer , Rolf Gulliksen , Monica Shaw , European Union , Nasdaq Stockholm , Chief Financial Officer , Peptide Drug Candidate , Marketing Authorization , Small Cap , News Publishing , Oncopeptides Ab Publ Stock Exchange , Press Release , Ole Onco Se0009414576 ,

Annual General Meeting in Oncopeptides AB

The shareholders in Oncopeptides AB , reg. no. 556596-6438, with registered office in the municipality of Stockholm, are hereby given notice to attend the Annual General Meeting to be held at. | April 24, 2023 ....

United Kingdom , Vastra Tradgardsgatan , Rolf Gulliksen , European Union , Annual General Meeting , Annual General , Peptide Drug Candidate , Marketing Authorization , Small Cap , Nasdaq Stockholm , News Publishing , Oncopeptides Ab Publ Stock Exchange , Press Release , Eld Onco Se0009414576 ,

Oncopeptides AB: Oncopeptides Chief Financial Officer Holger Lembrer takes office today

STOCKHOLM, Jan. 18, 2023 /PRNewswire/ Oncopeptides AB (publ.) (NASDAQ Stockholm: ONCO), a biotech company focused on commercialization, research, and development of therapies for difficult-to-treat ....

United Kingdom , Monica Shaw , Holger Lembrer , Rolf Gulliksen , Leadership Team , European Union , Global Head Of Corporate Communications , Chief Financial Officer , Global Head , Corporate Communications , Peptide Drug Candidate , Marketing Authorization , Small Cap , Chief Financial Officer Holger Lembrer ,